Breathe Well Live Well
|
Packers RB Eddie Lacy had bad asthma attack in second quarter
CBSSports.com Packers running back Eddie Lacy said he suffered an asthma attack in the sub-freezing temperatures at Lambeau Field on Sunday and had trouble breathing, reports the Milwaukee Journal Sentinel. Lacy took himself out in the second quarter and used his … |
View full post on asthma – Google News
New York Daily News |
Exclusive: Patients suffering from asthma make up nearly a quarter of Harlem …
New York Daily News There were 2,995 asthma-related emergency room visits; that was down from 3,388 last year and 3,131 in 2012, but the chronic disease has consistently ranked among the five top reasons listed for a visit, according to data obtained through a Freedom of … |
View full post on asthma – Google News
|
Studies: At Least A Quarter Of Asthma Cases Misdiagnosed
CBS Local NEW YORK (CBSNewYork) – New research indicates a large number of asthma patients have been misdiagnosed. As CBS 2?s Dr. Max Gomez reported, recent studies show that while 25 million Americans have been diagnosed with the disease, a starling … |
View full post on asthma – Google News
|
MediciNova Reports Third Quarter 2012 Results and Update on MN-221 …
NASDAQ The decrease in research and development expenses was mainly due to a decrease in spending on MN-221 due to the completion of the MN-221-CL-007 trial in patients with acute exacerbations of asthma, partially offset by an increase in spending on our … MediciNova Says Considering Cost, Timing and Design of Future Trials; FDA … |
View full post on asthma – Google News
 TV Equals |
Revolution Season 1 Review “No Quarter” – In Which the Most Effective Weapon …
TV Equals Revolution Season 1 Review “No Quarter” – In Which the Most Effective Weapon is Asthma. This week on Revolution in 'No Quarter', Charlie, Miles and Nora try to help the members of a rebel base that's under siege; Aaron and Maggie explore Grace's house … 'Revolution' Recap: The Bridge on the River Why? 'Revolution' Season 1 Episode 3: 'No Quarter' 'Revolution' Recap (Season 1, Episode 3): “No Quarter” |
View full post on asthma – Google News
 Evening Standard |
London 2012 Olympics: A quarter of Team GB suffer from exercise-induced asthma
Evening Standard A quarter of Britain's hopefuls including Tour de France champion Bradley Wiggins, swimmer Rebecca Adlington and marathon runner Paula Radcliffe all have asthma, according to charity Asthma UK. About three quarters of people with asthma say that … |
View full post on asthma – Google News
|
Halozyme Therapeutics Reports Third Quarter 2011 Financial Results
PR Newswire (press release) Baxter presented its Phase III data for the HyQ program at the American College of Allergy, Asthma & Immunology. HyQ was shown to be effective in subjects with Primary Immunodeficiency and enabled 94% of subjects to receive full 3 or 4-weekly doses of … Baxter Presents Phase III HyQ Efficacy and Tolerability Data at American … |
View full post on asthma – Google News
|
In the Treatment of Asthma, Merck's Singulair Accounts for More Than a Quarter …
MarketWatch (press release) Analysis of US patient-level claims data from Treatment Algorithms in Asthma also finds that more than half of newly diagnosed asthma patients that move to the second line of therapy within a year of diagnosis are treated with Singulair. … |
View full post on asthma – Google News
|
Array BioPharma Reports Results for the Fourth Quarter and Full Year of Fiscal …
MarketWatch (press release) In addition, Array initiated new clinical trials for two proprietary anti-inflammatory drugs: ARRY-797 for pain and ARRY-502 for asthma. ARRY-797 is being tested in a 150-patient Phase 2 chronic pain trial in osteoarthritis (OA) patients with top-line … |
View full post on asthma – Google News
|
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2011 Results
PR Newswire (press release) Palatin has started discussions with a number of potential development and marketing partners for PL-3994 for acute asthma, which would include the proof-of-concept human trial for asthma using a subcutaneously administered formulation and development … Palatin Technologies CEO Discusses F3Q2011 Results – Earnings Call Transcript |
View full post on asthma – Google News